Literature DB >> 17899465

A field study on the significance of vaccination against infectious bursal disease virus (IBDV) at the optimal time point in broiler flocks with maternally derived IBDV antibodies.

Hermann Block1, Karen Meyer-Block, Dierk E Rebeski, Heike Scharr, Sjaak de Wit, Karl Rohn, Silke Rautenschlein.   

Abstract

The right strategy for infectious bursal disease (IBD) control and its success rate under field conditions depends on hygiene management, IBD field pressure, level and variation in maternally derived IBD antibodies, and the IBD vaccine strains to be used. Usually, standard vaccination programmes are used, which are not always adapted to the specific conditions on the farm and to the immune status of chickens. Employing the "Deventer formula" may help to estimate the optimal time for vaccination for a specific flock based on the maternally derived antibody level, its variation, the genetic background of the chicken, and the IBD vaccine strain. Two field studies with 16 or 20 commercial broiler flocks were conducted, applying an intermediate IBD vaccine before, at the best, and after the estimated optimal vaccination time estimated by the "Deventer formula". These studies showed that flocks IBD-vaccinated between 1 day before, at, or up to 3 days after the estimated optimal time point developed detectable humoral immunity up to 14 days post vaccination. If birds had been vaccinated more than 1 day before the calculated optimal vaccination date, the humoral immune response was delayed or non-detectable until slaughter. The induction of humoral immunity correlated with the incidence of bursa lesions and IBDV detection by reverse transcriptase-polymerase chain reaction. As indicated in this study, under field conditions bursa lesions may develop later than predicted based on experimental experiences. The late incidence of bursa lesions after vaccination may be confused with field virus-induced lesions, in which case sequencing may offer a valuable tool for differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899465     DOI: 10.1080/03079450701589175

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  10 in total

1.  Ecological and life-history factors influencing the evolution of maternal antibody allocation: a phylogenetic comparison.

Authors:  Brianne Addison; Kirk C Klasing; W Douglas Robinson; Suzanne H Austin; Robert E Ricklefs
Journal:  Proc Biol Sci       Date:  2009-08-26       Impact factor: 5.349

2.  Risk factors associated with infectious bursal disease vaccination failures in broiler farms in Kenya.

Authors:  Wanzila Usyu Mutinda; Philip Njeru Nyaga; Paul Gichohi Mbuthia; Lilly Caroline Bebora; Gerald Muchemi
Journal:  Trop Anim Health Prod       Date:  2014-01-12       Impact factor: 1.559

3.  Quality Assessment of Day-Old Chickens on the Broiler Farms of Hong Kong.

Authors:  Omid Nekouei; Denis Yau; Brett MacKinnon; Ioannis Magouras; Anne Conan; Ibrahim Elsohaby; Surya Paudel; Dirk U Pfeiffer
Journal:  Animals (Basel)       Date:  2022-06-10       Impact factor: 3.231

4.  Assessment of impact of a novel infectious bursal disease (IBD) vaccination programme in breeders on IBD humoral antibody levels through the laying period.

Authors:  Daniel Parker; Sjaak de Wit; Helen Houghton; Francesco Prandini
Journal:  Vet Rec Open       Date:  2014-06-25

5.  Outbreaks of Virulent Infectious Bursal Disease in Flocks of Battery Cage Brooding System of Commercial Chickens.

Authors:  H B Aliyu; L Sa'idu; A Jamilu; A D Andamin; S O Akpavie
Journal:  J Vet Med       Date:  2016-08-11

6.  Determination of the optimal time of vaccination against infectious bursal disease virus (Gumboro) in Algeria.

Authors:  Omar Besseboua; Abdelhanine Ayad; Hama Benbarek
Journal:  Onderstepoort J Vet Res       Date:  2015-04-30       Impact factor: 1.792

7.  Combination of TLR2 and TLR3 agonists derepress infectious bursal disease virus vaccine-induced immunosuppression in the chicken.

Authors:  Khalid Bashir; Deepthi Kappala; Yogendra Singh; Javeed Ahmad Dar; Asok Kumar Mariappan; Ajay Kumar; Narayanan Krishnaswamy; Sohini Dey; Madhan Mohan Chellappa; Tapas Kumar Goswami; Vivek Kumar Gupta; Saravanan Ramakrishnan
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

8.  Efficacy of live attenuated, vector and immune complex infectious bursal disease virus (IBDV) vaccines in preventing field strain bursa colonization: A European multicentric study.

Authors:  Gema Ramon; Matteo Legnardi; Mattia Cecchinato; Christophe Cazaban; Claudia Maria Tucciarone; Laura Fiorentini; Lorenzo Gambi; Tamas Mato; Giacomo Berto; Kostas Koutoulis; Giovanni Franzo
Journal:  Front Vet Sci       Date:  2022-09-12

9.  Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris.

Authors:  Omid Taghavian; Holger Spiegel; Rüdiger Hauck; Hafez M Hafez; Rainer Fischer; Stefan Schillberg
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

10.  Infectious bursal disease virus infection leads to changes in the gut associated-lymphoid tissue and the microbiota composition.

Authors:  Li Li; Tereza Kubasová; Ivan Rychlik; Frederic J Hoerr; Silke Rautenschlein
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.